KPTI vs. META
Compare and contrast key facts about Karyopharm Therapeutics Inc. (KPTI) and Meta Platforms, Inc. (META).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KPTI or META.
Correlation
The correlation between KPTI and META is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KPTI vs. META - Performance Comparison
Key characteristics
KPTI:
-0.62
META:
1.56
KPTI:
-0.75
META:
2.06
KPTI:
0.92
META:
1.28
KPTI:
-0.53
META:
2.57
KPTI:
-1.19
META:
7.78
KPTI:
43.51%
META:
6.09%
KPTI:
84.43%
META:
30.33%
KPTI:
-98.76%
META:
-76.74%
KPTI:
-98.71%
META:
-5.68%
Fundamentals
KPTI:
$75.71M
META:
$1.78T
KPTI:
-$1.05
META:
$23.86
KPTI:
-0.15
META:
1.44
KPTI:
$114.69M
META:
$164.50B
KPTI:
$109.84M
META:
$134.34B
KPTI:
-$19.00M
META:
$81.63B
Returns By Period
In the year-to-date period, KPTI achieves a -9.80% return, which is significantly lower than META's 18.67% return. Over the past 10 years, KPTI has underperformed META with an annualized return of -31.96%, while META has yielded a comparatively higher 24.42% annualized return.
KPTI
-9.80%
-11.20%
-22.51%
-49.59%
-48.14%
-31.96%
META
18.67%
12.71%
30.86%
48.87%
27.21%
24.42%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KPTI vs. META — Risk-Adjusted Performance Rank
KPTI
META
KPTI vs. META - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Karyopharm Therapeutics Inc. (KPTI) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KPTI vs. META - Dividend Comparison
KPTI has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.22%.
| TTM | 2024 | |
|---|---|---|
KPTI Karyopharm Therapeutics Inc. | 0.00% | 0.00% |
META Meta Platforms, Inc. | 0.22% | 0.34% |
Drawdowns
KPTI vs. META - Drawdown Comparison
The maximum KPTI drawdown since its inception was -98.76%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for KPTI and META. For additional features, visit the drawdowns tool.
Volatility
KPTI vs. META - Volatility Comparison
Karyopharm Therapeutics Inc. (KPTI) has a higher volatility of 15.59% compared to Meta Platforms, Inc. (META) at 5.69%. This indicates that KPTI's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
KPTI vs. META - Financials Comparison
This section allows you to compare key financial metrics between Karyopharm Therapeutics Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities